首页 > 最新文献

Endocrine and Metabolic Science最新文献

英文 中文
Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice 瑞士系小鼠短期糖皮质激素过量对骨骼影响的稀疏剂量依赖性差异
Q3 Medicine Pub Date : 2021-12-01 DOI: 10.1016/j.endmts.2021.100114
Mikkel Bo Brent, Annemarie Brüel , Jesper Skovhus Thomsen

Glucocorticoid-induced osteoporosis (GIO) is the most common causes of secondary osteoporosis. Several laboratory animals have been employed to model GIO, and multiple routes of administration have been utilized. Prednisolone delivered by pellets implanted subcutaneously has been suggested as a less invasive alternative to daily injections, but how the severity of GIO varies between doses and the efficacy of short-term administration are not entirely elucidated. We investigated the skeletal effects of short-term exposure to glucocorticoid (GC) excess from implantable slow-release prednisolone pellets using two different doses (2.8 and 5.4 mg/kg/d). Forty-eight female Swiss mice were randomly allocated to the following four groups: 1: Baseline, 2: Placebo pellet (PP), 3: GC 5 mg, and 4: GC 10 mg. The study lasted four weeks. The musculoskeletal effects of GC were assessed by DXA, µCT, mechanical testing, dynamic bone histomorphometry, and histological quantification of bone and muscle cells. Both doses of GC significantly reduced bone mineral density, cortical mineralizing surfaces and mineral apposition rate, trabecular osteoid-covered surfaces, and rectus femoris muscle cell cross-sectional area compared with PP. In addition, the high dose of GC significantly reduced mid-diaphyseal bone strength compared with PP. Either dose had only minor impact on trabecular microstructure, while no negative effect was found on mid-diaphyseal cortical thickness. In conclusion, prednisolone pellet-induced short-term GC excess resulted in osteopenia, reduced bone formation indices, and only few dose-dependent differences were found.

糖皮质激素诱导的骨质疏松症(GIO)是继发性骨质疏松症最常见的原因。一些实验动物被用来模拟GIO,并采用多种给药途径。经皮下植入的泼尼松龙颗粒被认为是每日注射的一种侵入性较小的替代方案,但GIO的严重程度如何在剂量和短期给药的效果之间变化尚未完全阐明。我们使用两种不同剂量(2.8和5.4 mg/kg/d)研究了短期暴露于可植入的缓释强的松龙微丸中过量糖皮质激素对骨骼的影响。48只瑞士雌性小鼠随机分为以下四组:1:基线,2:安慰剂颗粒(PP), 3: GC 5 mg, 4: GC 10 mg。这项研究持续了四周。通过DXA、微CT、力学测试、动态骨组织形态测量以及骨和肌肉细胞的组织学定量来评估GC对肌肉骨骼的影响。与PP相比,两种剂量的GC均显著降低了骨矿物质密度、皮质矿化面和矿物附着率、骨小梁骨覆盖面和股直肌细胞截面积。此外,高剂量的GC显著降低了骨干中骨强度。两种剂量均对骨干小梁微结构有轻微影响,而对骨干中皮质厚度无负面影响。综上所述,强的松龙颗粒诱导的短期GC过量导致骨质减少,骨形成指数降低,且剂量依赖性差异很小。
{"title":"Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice","authors":"Mikkel Bo Brent,&nbsp;Annemarie Brüel ,&nbsp;Jesper Skovhus Thomsen","doi":"10.1016/j.endmts.2021.100114","DOIUrl":"10.1016/j.endmts.2021.100114","url":null,"abstract":"<div><p>Glucocorticoid-induced osteoporosis (GIO) is the most common causes of secondary osteoporosis. Several laboratory animals have been employed to model GIO, and multiple routes of administration have been utilized. Prednisolone delivered by pellets implanted subcutaneously has been suggested as a less invasive alternative to daily injections, but how the severity of GIO varies between doses and the efficacy of short-term administration are not entirely elucidated. We investigated the skeletal effects of short-term exposure to glucocorticoid (GC) excess from implantable slow-release prednisolone pellets using two different doses (2.8 and 5.4 mg/kg/d). Forty-eight female Swiss mice were randomly allocated to the following four groups: 1: Baseline, 2: Placebo pellet (PP), 3: GC 5 mg, and 4: GC 10 mg. The study lasted four weeks. The musculoskeletal effects of GC were assessed by DXA, µCT, mechanical testing, dynamic bone histomorphometry, and histological quantification of bone and muscle cells. Both doses of GC significantly reduced bone mineral density, cortical mineralizing surfaces and mineral apposition rate, trabecular osteoid-covered surfaces, and rectus femoris muscle cell cross-sectional area compared with PP. In addition, the high dose of GC significantly reduced mid-diaphyseal bone strength compared with PP. Either dose had only minor impact on trabecular microstructure, while no negative effect was found on mid-diaphyseal cortical thickness. In conclusion, prednisolone pellet-induced short-term GC excess resulted in osteopenia, reduced bone formation indices, and only few dose-dependent differences were found.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666396121000376/pdfft?md5=9eaba365d63802e19286066a74cca662&pid=1-s2.0-S2666396121000376-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47228639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effects of a Longitudinal Peer to Peer Support Group Foot Care Intervention Program in a Prospective Cohort of Patients with Diabetes Mellitus 纵向同伴对同伴支持小组足部护理干预计划在前瞻性糖尿病患者队列中的效果
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100104
Nivita D. Sharma , Wahid Khan

Aim: To evaluate the clinical success of a first and longitudinal peer-to-peer support group foot care intervention program in a prospective cohort of persons with diabetes in a disadvantaged population.

Method: A prospective cohort-based study design was implemented using standard protocols. A knowledge, attitude, and practice (KAP) instrument toward foot care was administered to persons with type 2 diabetes mellitus before and after the intervention program was implemented. The KAP instrument achieved very high overall and component Cronbach alpha reliability.

Results: The average age of the patients at the time of the pre-intervention was 57.9 years (SD ± 9.8). Sixty-nine percent are females, 44.5% are natives (I-Taukei) and 55.5% are migrant Indians (Indo-Fijians), and 76.4% completed high school. Univariate analyses reveal a highly statistically significant and clinically meaningful increase in the component KAP scores following the foot care intervention program. Results from multiple regression analyses adjusting for patient demographics and confounders show significant improvements in patients’ KAP toward foot care.

Conclusion: The success and efficacy of this foot care intervention program suggests that other countries with limited resources battling diabetes driven foot care hospitalizations and amputations can implement a similar cost-efficient public health education and awareness model as an initial step. This approach can alleviate the stress on healthcare systems during a pandemic.

目的:评价在弱势群体糖尿病患者的前瞻性队列中首次和纵向点对点支持小组足部护理干预项目的临床成功。方法:采用前瞻性队列研究设计,采用标准方案。在干预计划实施前后,对2型糖尿病患者进行足部护理知识、态度和实践(KAP)测试。KAP仪器获得了非常高的整体和成分Cronbach α信度。结果:干预前患者平均年龄57.9岁(SD±9.8)。69%是女性,44.5%是本地人(I-Taukei), 55.5%是移民印度人(印度-斐济人),76.4%完成了高中学业。单变量分析显示,足部护理干预方案后,KAP成分得分有高度统计学意义和临床意义的增加。调整患者人口统计学和混杂因素的多元回归分析结果显示,患者对足部护理的KAP有显著改善。结论:该足部护理干预项目的成功和效果表明,其他资源有限的国家在应对糖尿病导致的足部护理住院和截肢方面可以实施类似的具有成本效益的公共卫生教育和意识模式,作为第一步。这种方法可以减轻大流行期间卫生保健系统的压力。
{"title":"Effects of a Longitudinal Peer to Peer Support Group Foot Care Intervention Program in a Prospective Cohort of Patients with Diabetes Mellitus","authors":"Nivita D. Sharma ,&nbsp;Wahid Khan","doi":"10.1016/j.endmts.2021.100104","DOIUrl":"10.1016/j.endmts.2021.100104","url":null,"abstract":"<div><p>Aim: To evaluate the clinical success of a first and longitudinal peer-to-peer support group foot care intervention program in a prospective cohort of persons with diabetes in a disadvantaged population.</p><p>Method: A prospective cohort-based study design was implemented using standard protocols. A knowledge, attitude, and practice (KAP) instrument toward foot care was administered to persons with type 2 diabetes mellitus before and after the intervention program was implemented. The KAP instrument achieved very high overall and component Cronbach alpha reliability.</p><p>Results: The average age of the patients at the time of the pre-intervention was 57.9 years (SD ± 9.8). Sixty-nine percent are females, 44.5% are natives (I-Taukei) and 55.5% are migrant Indians (Indo-Fijians), and 76.4% completed high school. Univariate analyses reveal a highly statistically significant and clinically meaningful increase in the component KAP scores following the foot care intervention program. Results from multiple regression analyses adjusting for patient demographics and confounders show significant improvements in patients’ KAP toward foot care.</p><p>Conclusion: The success and efficacy of this foot care intervention program suggests that other countries with limited resources battling diabetes driven foot care hospitalizations and amputations can implement a similar cost-efficient public health education and awareness model as an initial step. This approach can alleviate the stress on healthcare systems during a pandemic.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"96929029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective 2型糖尿病胰岛素治疗的开始和强化:医生的障碍和解决方案-印度的观点
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100103
Viswanathan Mohan , Jagat J Mukherjee , Ashok K Das , Krishna Seshadri , Arundhati Dasgupta

The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide, and its complications are highly contributing to mortality. Compared to oral hypoglycemic agents, reduction in HbA1c is maximum with insulin therapy. Evidence suggests the potential benefits of achieving normoglycemia with early intensive insulin therapy. Despite the high levels of uncontrolled T2DM in Indian patients, the use of insulin remains suboptimal. Initiation of insulin therapy in patients with T2DM is often inappropriately delayed due to physician's barriers. These include physicians’ inadequacy of skill and time required for insulin therapy, perceived complications of insulin therapy and perceived lack of treatment benefit. These barriers can be overcome by physician education and training, using effective patient education methods and tools, and bridging gaps to improve adherence by the patients. Pharmaceutical industry, government health authorities, medical institutions, healthcare professionals and patients can help to overcome the clinical inertia for the initiation and titration of insulin in patients with type 2 diabetes.

2型糖尿病(T2DM)的患病率在全球范围内呈上升趋势,其并发症是导致死亡率的重要因素。与口服降糖药相比,胰岛素治疗对HbA1c的降低效果最大。有证据表明,早期强化胰岛素治疗可使血糖达到正常水平。尽管印度患者中未控制的T2DM水平很高,但胰岛素的使用仍然不理想。由于医生的障碍,T2DM患者胰岛素治疗的开始常常不适当地延迟。这些因素包括医生对胰岛素治疗的技能和时间的不足,胰岛素治疗的并发症和治疗效果的缺乏。这些障碍可以通过医生教育和培训,使用有效的患者教育方法和工具,弥合差距以提高患者的依从性来克服。制药行业、政府卫生当局、医疗机构、保健专业人员和患者可以帮助克服2型糖尿病患者开始和滴定胰岛素的临床惯性。
{"title":"Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective","authors":"Viswanathan Mohan ,&nbsp;Jagat J Mukherjee ,&nbsp;Ashok K Das ,&nbsp;Krishna Seshadri ,&nbsp;Arundhati Dasgupta","doi":"10.1016/j.endmts.2021.100103","DOIUrl":"10.1016/j.endmts.2021.100103","url":null,"abstract":"<div><p>The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide, and its complications are highly contributing to mortality. Compared to oral hypoglycemic agents, reduction in HbA1c is maximum with insulin therapy. Evidence suggests the potential benefits of achieving normoglycemia with early intensive insulin therapy. Despite the high levels of uncontrolled T2DM in Indian patients, the use of insulin remains suboptimal. Initiation of insulin therapy in patients with T2DM is often inappropriately delayed due to physician's barriers. These include physicians’ inadequacy of skill and time required for insulin therapy, perceived complications of insulin therapy and perceived lack of treatment benefit. These barriers can be overcome by physician education and training, using effective patient education methods and tools, and bridging gaps to improve adherence by the patients. Pharmaceutical industry, government health authorities, medical institutions, healthcare professionals and patients can help to overcome the clinical inertia for the initiation and titration of insulin in patients with type 2 diabetes.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"105231757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hsps70 and 90 protect the heart of hyperthyroid rats via nitric oxide production and VEGF inhibition of apoptosis Hsps70和90通过产生一氧化氮和VEGF抑制细胞凋亡来保护甲状腺功能亢进大鼠的心脏
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100097
Ayodeji Folorunsho Ajayi , Olubodun Micheal Lateef , Oluwadunsi Iyanuoluwa Adebayo , Emmanuel Tayo Adebayo

Background

. Changes occur in the heart's contractile and metabolic demands during altered thyroid states. The changes may be associated with alterations in the cellular signaling of vascular endothelial growth factors (VEGF) and expressions of heat shock proteins (Hsp).

Aim

. This study examined the effects of thyroid dysfunction on VEGF, hsp70, and hsp 90 concentrations in the heart tissues of dysthyroid rats.

Methods

. Wistar rats were allocated into control, hypothyroid (Carbimazole-treated), and hyperthyroid (Levothyroxine-treated) groups randomly (n=7). Thyroid function test, body weight changes, serum creatinine kinase (CK-MB), cardiac troponin I (cTnI) and troponin T (cTnT), NO, VEGF, Hsp70, and Hsp 90 were determined using standard methods.

Results

. There was a significant increase (P<0.05) in NO, VEGF, Hsp70, and Hsp 90 levels in the hyperthyroid group and reduced expression in the hypothyroid group compared to the control. Carbimazole treatment led to a significant increase in lipid peroxidation and CK-MB level, with a substantial decrease in the superoxide dismutase (SOD) activity in the hypothyroid group.

Conclusion

. Increased expression of Hsp70 and 90 in hyperthyroid rats' heart tissue play essential roles in protecting the heart from oxidative damage and cardiovascular derangements via enhancement of nitric oxide production and apoptosis inhibition by VEGF.

背景。甲状腺状态改变时,心脏的收缩和代谢需求发生变化。这些变化可能与血管内皮生长因子(VEGF)的细胞信号传导和热休克蛋白(Hsp)表达的改变有关。本研究观察甲状腺功能障碍对甲状腺功能障碍大鼠心脏组织中VEGF、hsp70、hsp90浓度的影响。Wistar大鼠随机分为对照组、甲亢组(左旋甲状腺素组)和甲亢组(卡比马唑组)。采用标准方法检测甲状腺功能、体重变化、血清肌酐激酶(CK-MB)、心肌肌钙蛋白I (cTnI)、肌钙蛋白T (cTnT)、NO、VEGF、Hsp70、hsp90。甲状腺功能亢进组NO、VEGF、Hsp70、hsp90水平较对照组显著升高(p < 0.05),甲状腺功能低下组表达较对照组降低。卡咪唑治疗导致甲状腺功能减退组脂质过氧化和CK-MB水平显著升高,超氧化物歧化酶(SOD)活性显著降低。在甲状腺功能亢进大鼠心脏组织中,Hsp70和90的表达增加,通过促进一氧化氮的产生和VEGF抑制细胞凋亡,在保护心脏免受氧化损伤和心血管紊乱中发挥重要作用。
{"title":"Hsps70 and 90 protect the heart of hyperthyroid rats via nitric oxide production and VEGF inhibition of apoptosis","authors":"Ayodeji Folorunsho Ajayi ,&nbsp;Olubodun Micheal Lateef ,&nbsp;Oluwadunsi Iyanuoluwa Adebayo ,&nbsp;Emmanuel Tayo Adebayo","doi":"10.1016/j.endmts.2021.100097","DOIUrl":"10.1016/j.endmts.2021.100097","url":null,"abstract":"<div><h3>Background</h3><p><strong>.</strong> Changes occur in the heart's contractile and metabolic demands during altered thyroid states. The changes may be associated with alterations in the cellular signaling of vascular endothelial growth factors (VEGF) and expressions of heat shock proteins (Hsp).</p></div><div><h3>Aim</h3><p><strong>.</strong> This study examined the effects of thyroid dysfunction on VEGF, hsp70, and hsp 90 concentrations in the heart tissues of dysthyroid rats.</p></div><div><h3>Methods</h3><p><strong>.</strong> Wistar rats were allocated into control, hypothyroid (Carbimazole-treated), and hyperthyroid (Levothyroxine-treated) groups randomly (<em>n</em>=7). Thyroid function test, body weight changes, serum creatinine kinase (CK-MB), cardiac troponin I (cTnI) and troponin T (cTnT), NO, VEGF, Hsp70, and Hsp 90 were determined using standard methods.</p></div><div><h3>Results</h3><p><strong>.</strong> There was a significant increase (<em>P</em>&lt;0.05) in NO, VEGF, Hsp70, and Hsp 90 levels in the hyperthyroid group and reduced expression in the hypothyroid group compared to the control. Carbimazole treatment led to a significant increase in lipid peroxidation and CK-MB level, with a substantial decrease in the superoxide dismutase (SOD) activity in the hypothyroid group.</p></div><div><h3>Conclusion</h3><p><strong>.</strong> Increased expression of Hsp70 and 90 in hyperthyroid rats' heart tissue play essential roles in protecting the heart from oxidative damage and cardiovascular derangements via enhancement of nitric oxide production and apoptosis inhibition by VEGF.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100097","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"96458718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of black pepper, turmeric and ajwa date on the endocrine pancreas of the experimentally induced diabetes in wister albino rats: A histological and immunohistochemical study 黑胡椒、姜黄和红枣对实验性糖尿病大鼠内分泌胰腺的影响:组织学和免疫组化研究
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100098
Maliha Sarfraz , Tanweer Khaliq , Rahman M. Hafizur , Sayed Ali Raza , Hayat Ullah

Background

Diabetes is now a global problem and millions of people are suffering all over the world. Reports exist for the allopathic use of turmeric, black pepper, and date palm as an antidiabetic and antioxidant agent.

Aim

The current study was designed to assess the antihyperglycemic, antioxidants and antihyperlipidemic consequences of black pepper (BP), turmeric (T), ajwa pulp (AP), and ajwa seeds (AS) in alloxan-induced diabetic rats.

Methodology

Diabetes was induced by a single intraperitoneal injection of alloxan (150 mg/kg b.w) in rats. They were randomly divided into 11 groups of 18 male and 18 female rats each. Group-1 normal control, group-2 diabetic control, group-3 was administered with glibenclamide (10 mg/kg), group-4 was administered with aqueous extract of BP (50 mg/kg), group-5, 6, 7 were administered with T, AP and AS (500 mg/kg) and group-8, 9, 10, 11 were administered with different combinations of aqueous extract (500 mg/kg) once in a day for eight weeks. The antihyperglycemic potential was determined through biochemical and histological investigations of the experimental animals at the end of the experiment.

Results

The results of the study revealed that treatments improved glucose (229.53 mg/dL), Ghb (7.68%), insulin (13.63 U/L), Tg (95.92 mg/dL), Tc (152.86 mg/dL), HDL (23.22 mg/dL), LDL (110.30 mg/dL), TAC (1.89 mmol/L) and TOS (20.05 μmol/L) in comparison to diabetic control rats after 8 weeks of study period. Histological and immunohistochemical investigation of tissues exhibited severe changes in the pancreas of diabetic rats and treatments modulate these changes; this improvement in cells may explain the antidiabetic effects.

Conclusion

It is concluded that aqueous extract of BP+AS; and BP+T+AP+AS could be promising nutraceutical therapy for diabetes management and its associated complications.

糖尿病现在是一个全球性问题,全世界有数百万人患有糖尿病。有报道称姜黄、黑胡椒和椰枣作为抗糖尿病和抗氧化剂的对抗疗法使用。目的本研究旨在评价黑胡椒(BP)、姜黄(T)、ajwa果肉(AP)和ajwa种子(AS)对四氧嘧啶诱导的糖尿病大鼠的降糖、抗氧化剂和降血脂作用。方法采用单次腹腔注射四氧嘧啶(150 mg/kg b.w)诱导大鼠糖尿病。它们被随机分为11组,每组18只公鼠和18只母鼠。1组正常对照组、2组糖尿病对照组、3组给予格列本脲(10 mg/kg), 4组给予BP水提物(50 mg/kg), 5、6、7组给予T、AP、AS (500 mg/kg), 8、9、10、11组给予不同组合水提物(500 mg/kg),每天1次,连用8周。实验结束时对实验动物进行生化和组织学检查,测定其降糖潜能。结果8周后,与糖尿病对照组相比,葡萄糖(229.53 mg/dL)、Ghb(7.68%)、胰岛素(13.63 U/L)、Tg (95.92 mg/dL)、Tc (152.86 mg/dL)、HDL (23.22 mg/dL)、LDL (110.30 mg/dL)、TAC (1.89 mmol/L)和TOS (20.05 μmol/L)均得到改善。对糖尿病大鼠胰腺组织的组织学和免疫组织化学调查显示,胰腺组织发生了严重的变化,治疗可以调节这些变化;细胞的这种改善可以解释其抗糖尿病作用。结论BP+AS水提物;BP+T+AP+AS可能是治疗糖尿病及其相关并发症的有前途的营养品疗法。
{"title":"Effect of black pepper, turmeric and ajwa date on the endocrine pancreas of the experimentally induced diabetes in wister albino rats: A histological and immunohistochemical study","authors":"Maliha Sarfraz ,&nbsp;Tanweer Khaliq ,&nbsp;Rahman M. Hafizur ,&nbsp;Sayed Ali Raza ,&nbsp;Hayat Ullah","doi":"10.1016/j.endmts.2021.100098","DOIUrl":"10.1016/j.endmts.2021.100098","url":null,"abstract":"<div><h3>Background</h3><p>Diabetes is now a global problem and millions of people are suffering all over the world. Reports exist for the allopathic use of turmeric, black pepper, and date palm as an antidiabetic and antioxidant agent.</p></div><div><h3>Aim</h3><p>The current study was designed to assess the antihyperglycemic, antioxidants and antihyperlipidemic consequences of black pepper (BP), turmeric (T), ajwa pulp (AP), and ajwa seeds (AS) in alloxan-induced diabetic rats.</p></div><div><h3>Methodology</h3><p>Diabetes was induced by a single intraperitoneal injection of alloxan (150 mg/kg b.w) in rats. They were randomly divided into 11 groups of 18 male and 18 female rats each. Group-1 normal control, group-2 diabetic control, group-3 was administered with glibenclamide (10 mg/kg), group-4 was administered with aqueous extract of BP (50 mg/kg), group-5, 6, 7 were administered with T, AP and AS (500 mg/kg) and group-8, 9, 10, 11 were administered with different combinations of aqueous extract (500 mg/kg) once in a day for eight weeks. The antihyperglycemic potential was determined through biochemical and histological investigations of the experimental animals at the end of the experiment.</p></div><div><h3>Results</h3><p>The results of the study revealed that treatments improved glucose (229.53 mg/dL), Ghb (7.68%), insulin (13.63 U/L), Tg (95.92 mg/dL), Tc (152.86 mg/dL), HDL (23.22 mg/dL), LDL (110.30 mg/dL), TAC (1.89 mmol/L) and TOS (20.05 μmol/L) in comparison to diabetic control rats after 8 weeks of study period. Histological and immunohistochemical investigation of tissues exhibited severe changes in the pancreas of diabetic rats and treatments modulate these changes; this improvement in cells may explain the antidiabetic effects.</p></div><div><h3>Conclusion</h3><p>It is concluded that aqueous extract of BP+AS; and BP+T+AP+AS could be promising nutraceutical therapy for diabetes management and its associated complications.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100098","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"110494760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
ACE ID gene polymorphism contributes to chronic kidney disease progression but not NOS3 gene among Type 2 diabetes with nephropathy patients 在2型糖尿病合并肾病患者中,ACE ID基因多态性对慢性肾病进展有影响,而NOS3基因无影响
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100100
Deepashree G A , Ramprasad E , Jayakumar M , Solomon F D Paul , Gnanasambandan R

Aim

Diabetic nephropathy (DN) is one of the major life-threatening complications of diabetes and it leads to end-stage renal disease. Altered angiotension converting enzyme and nitric oxide synthase are probably the cause of initiation and the progression of diabetic nephropathy. The present study aims to investigate the effect of ACE ID and NOS3 VNTR gene polymorphisms on the progression of chronic kidney disease among diabetic nephropathy.

Methods

253 DN patients and 104 controls were genotyped for ACE ID and NOS3 VNTR polymorphisms by following PCR-RFLP method. The diabetic nephropathy cases were divided into two groups based on CKD stages: 138 DN cases were at early stage (CKD1 to CKD3) and 115 DN cases were at advanced stage (CKD4 and CKD5). Association χ2 and univariate analysis were performed.

Results

A significant difference was found in genotype frequencies of ACE ID and NOS3 VNTR polymorphisms between the DN patients and the controls. On univariate analysis, the DD genotype of ACE gene was found to have a significant association with the advancement of CKD in DN (OR=0.37; 95 % CI=0.14–0.94; p=0.033).

Conclusions

The results suggest the association of ACE ID and NOS3 VNTR polymorphism with diabetic nephropathy in South Indian population. Furthermore, the present study evidences the association between DD genotype of ACE gene and advancement of CKD progression in DN.

糖尿病肾病(DN)是糖尿病的主要并发症之一,可导致终末期肾脏疾病。血管紧张转换酶和一氧化氮合酶的改变可能是糖尿病肾病发生和发展的原因。本研究旨在探讨ACE ID和NOS3 VNTR基因多态性对糖尿病肾病患者慢性肾病进展的影响。方法采用PCR-RFLP方法对253例DN患者和104例对照组进行ACE ID和NOS3 VNTR多态性基因分型。根据CKD分期将糖尿病肾病患者分为两组:早期肾病138例(CKD1 ~ CKD3),晚期肾病115例(CKD4、CKD5)。进行关联χ2和单因素分析。结果肾病患者与对照组ACE ID和NOS3 VNTR多态性基因型频率差异有统计学意义。单因素分析发现,ACE基因DD基因型与肾病患者CKD的进展有显著相关性(OR=0.37;95% ci = 0.14-0.94;p = 0.033)。结论ACE ID和NOS3 VNTR多态性与南印度人群糖尿病肾病有关。此外,本研究还证实了ACE基因DD型与肾病患者CKD进展的相关性。
{"title":"ACE ID gene polymorphism contributes to chronic kidney disease progression but not NOS3 gene among Type 2 diabetes with nephropathy patients","authors":"Deepashree G A ,&nbsp;Ramprasad E ,&nbsp;Jayakumar M ,&nbsp;Solomon F D Paul ,&nbsp;Gnanasambandan R","doi":"10.1016/j.endmts.2021.100100","DOIUrl":"10.1016/j.endmts.2021.100100","url":null,"abstract":"<div><h3>Aim</h3><p>Diabetic nephropathy (DN) is one of the major life-threatening complications of diabetes and it leads to end-stage renal disease. Altered angiotension converting enzyme and nitric oxide synthase are probably the cause of initiation and the progression of diabetic nephropathy. The present study aims to investigate the effect of ACE ID and NOS3 VNTR gene polymorphisms on the progression of chronic kidney disease among diabetic nephropathy.</p></div><div><h3>Methods</h3><p>253 DN patients and 104 controls were genotyped for ACE ID and NOS3 VNTR polymorphisms by following PCR-RFLP method. The diabetic nephropathy cases were divided into two groups based on CKD stages: 138 DN cases were at early stage (CKD1 to CKD3) and 115 DN cases were at advanced stage (CKD4 and CKD5). Association χ2 and univariate analysis were performed.</p></div><div><h3>Results</h3><p>A significant difference was found in genotype frequencies of ACE ID and NOS3 VNTR polymorphisms between the DN patients and the controls. On univariate analysis, the DD genotype of ACE gene was found to have a significant association with the advancement of CKD in DN (OR=0.37; 95 % CI=0.14–0.94; p=0.033).</p></div><div><h3>Conclusions</h3><p>The results suggest the association of ACE ID and NOS3 VNTR polymorphism with diabetic nephropathy in South Indian population. Furthermore, the present study evidences the association between DD genotype of ACE gene and advancement of CKD progression in DN.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"100795630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Oral ethinylestradiol–levonorgestrel therapy counteracts fructose-induced renal metabolic impairment in female rats 口服炔雌醇-左炔诺孕酮治疗可抵消果糖诱导的雌性大鼠肾脏代谢损伤
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100099
Kehinde Samuel Olaniyi , Isaiah Woru Sabinari , Lawrence Aderemi Olatunji

Background: The excessive intake of fructose (FRD) induces insulin resistance (IR)-associated renal impairment. Similarly, the use of estrogen-progestin oral contraceptive therapy (EEL) has been associated with cardiometabolic syndrome, and its non-contraceptive benefits particularly in metabolic pathologies remain inconclusive. Therefore, the present study investigated the effects of EEL on renal metabolic function in rats exposed to FRD.

Methods: Female rats received vehicle (po), EEL (1.0 µg ethinylestradiol+5.0 µg levonorgestrel.), fructose (10%; w/v) and EEL+FRD respectively for 8 weeks. All data were expressed as means ± SEM and significance were accepted at p<0.05.

Results: Data revealed that FRD/EEL caused IR with correspondent increased plasma/renal lipid, decreased glucose-6-dehydrogenase (G6PD), glutathione (GSH) and renal NO/adenosine. FRD but not EEL increased (p<0.05) renal glycogen and decreased (p<0.05) plasma NO/adenosine and pancreatic beta-cell function. These alterations were attenuated when EEL was administered with FRD.

Conclusion: The study demonstrates that FRD causes renal impairments accompanied by deficient NO/adenosine concentration and defective G6PD/GSH-dependent antioxidant defense. The findings also suggest that EEL blots the renal effects of FRD.

背景:过量摄入果糖(FRD)可诱导胰岛素抵抗(IR)相关的肾脏损害。同样,使用雌激素-黄体酮口服避孕药治疗(EEL)与心脏代谢综合征有关,其非避孕益处,特别是在代谢病理方面仍不确定。因此,本研究探讨了EEL对FRD暴露大鼠肾脏代谢功能的影响。方法:雌性大鼠给药(po)、EEL(1.0µg炔雌醇+5.0µg左炔诺孕酮)、果糖(10%;w/v)和EEL+FRD分别治疗8周。所有数据以均数±SEM表示,显著性以p<0.05接受。结果:数据显示,FRD/EEL引起IR,相应的血浆/肾脏脂质升高,葡萄糖-6-脱氢酶(G6PD)、谷胱甘肽(GSH)和肾脏NO/腺苷降低。FRD升高了肾糖原(p < 0.05),降低了血浆NO/腺苷和胰岛β细胞功能(p < 0.05)。当与FRD一起给药时,这些改变减弱。结论:研究表明,FRD引起肾损害,并伴有NO/腺苷浓度不足和G6PD/ gsh依赖性抗氧化防御缺陷。研究结果还表明,EEL可以抑制FRD对肾脏的影响。
{"title":"Oral ethinylestradiol–levonorgestrel therapy counteracts fructose-induced renal metabolic impairment in female rats","authors":"Kehinde Samuel Olaniyi ,&nbsp;Isaiah Woru Sabinari ,&nbsp;Lawrence Aderemi Olatunji","doi":"10.1016/j.endmts.2021.100099","DOIUrl":"10.1016/j.endmts.2021.100099","url":null,"abstract":"<div><p>Background: The excessive intake of fructose (FRD) induces insulin resistance (IR)-associated renal impairment. Similarly, the use of estrogen-progestin oral contraceptive therapy (EEL) has been associated with cardiometabolic syndrome, and its non-contraceptive benefits particularly in metabolic pathologies remain inconclusive. Therefore, the present study investigated the effects of EEL on renal metabolic function in rats exposed to FRD.</p><p>Methods: Female rats received vehicle (po), EEL (1.0 µg ethinylestradiol+5.0 µg levonorgestrel.), fructose (10%; w/v) and EEL+FRD respectively for 8 weeks. All data were expressed as means ± SEM and significance were accepted at <em>p</em>&lt;0.05.</p><p>Results: Data revealed that FRD/EEL caused IR with correspondent increased plasma/renal lipid, decreased glucose-6-dehydrogenase (G6PD), glutathione (GSH) and renal NO/adenosine. FRD but not EEL increased (<em>p</em>&lt;0.05) renal glycogen and decreased (<em>p</em>&lt;0.05) plasma NO/adenosine and pancreatic beta-cell function. These alterations were attenuated when EEL was administered with FRD.</p><p>Conclusion: The study demonstrates that FRD causes renal impairments accompanied by deficient NO/adenosine concentration and defective G6PD/GSH-dependent antioxidant defense. The findings also suggest that EEL blots the renal effects of FRD.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113353238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India 格列齐特在安全引导2型糖尿病患者走向正常血糖中的作用:来自印度的专家意见
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100102
Subhash Wangnoo , M. Shunmugavelu , Sagili Vijaya Bhaskar Reddy , Vijay Negalur , Shreerang Godbole , Vinay K Dhandhania , Nareen Krishna , Kumar Gaurav

Navigating safely towards euglycemia in type 2 diabetes mellitus (T2DM) is a real challenge in the current clinical practice despite availability of a number of glucose-lowering drugs; major barriers are hypoglycemia and weight gain. Sulfonylureas (SUs) have been recommended as one of the most common choice of add-on therapy to metformin (used as first line therapy). They are used extensively in Southeast Asia due to their high efficacy and low cost. However, there have been concerns regarding hypoglycemia, weight gain and cardiovascular safety with SUs. There is a need for an oral molecule that does not cause weight gain, has low risk of causing hypoglycemia, which can be used to navigate safely towards euglycemia with minimal constraints. Literature has shown that gliclazide provides consistent glycemic control with fewer hypoglycemic episodes and has long-term micro- and macrovascular benefits. This expert opinion was developed to highlight the role of SUs, and gliclazide in particular, in navigating effectively and safely towards the desired glycemic control in T2DM.

在目前的临床实践中,尽管有许多降糖药物可用,但如何安全地引导2型糖尿病(T2DM)患者达到正常血糖是一个真正的挑战;主要障碍是低血糖和体重增加。磺脲类(SUs)已被推荐为二甲双胍(用作一线治疗)的最常见的附加治疗选择之一。由于其疗效高、成本低,在东南亚被广泛使用。然而,有关于低血糖、体重增加和心血管安全的担忧。需要一种口服分子,它不会导致体重增加,导致低血糖的风险低,可以在最小的限制下安全地引导到高血糖。文献表明,格列齐特提供持续的血糖控制,减少低血糖发作,并具有长期的微血管和大血管益处。这一专家意见的提出是为了强调SUs,特别是格列齐特在有效和安全地控制T2DM患者所需血糖方面的作用。
{"title":"Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India","authors":"Subhash Wangnoo ,&nbsp;M. Shunmugavelu ,&nbsp;Sagili Vijaya Bhaskar Reddy ,&nbsp;Vijay Negalur ,&nbsp;Shreerang Godbole ,&nbsp;Vinay K Dhandhania ,&nbsp;Nareen Krishna ,&nbsp;Kumar Gaurav","doi":"10.1016/j.endmts.2021.100102","DOIUrl":"10.1016/j.endmts.2021.100102","url":null,"abstract":"<div><p>Navigating safely towards euglycemia in type 2 diabetes mellitus (T2DM) is a real challenge in the current clinical practice despite availability of a number of glucose-lowering drugs; major barriers are hypoglycemia and weight gain. Sulfonylureas (SUs) have been recommended as one of the most common choice of add-on therapy to metformin (used as first line therapy). They are used extensively in Southeast Asia due to their high efficacy and low cost. However, there have been concerns regarding hypoglycemia, weight gain and cardiovascular safety with SUs. There is a need for an oral molecule that does not cause weight gain, has low risk of causing hypoglycemia, which can be used to navigate safely towards euglycemia with minimal constraints. Literature has shown that gliclazide provides consistent glycemic control with fewer hypoglycemic episodes and has long-term micro- and macrovascular benefits. This expert opinion was developed to highlight the role of SUs, and gliclazide in particular, in navigating effectively and safely towards the desired glycemic control in T2DM.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"112875243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Text Mining and Grounded Theory for Appraising the Self-Management Indicators of Diabetes Mobile Apps 糖尿病手机app自我管理指标评价的文本挖掘与扎根理论
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100101
Chinedu I. Ossai , Nilmini Wickramasinghe

Background: Understanding diabetes mobile apps functionality is fundamental to diabetes self-management because of the reliance of many patients with diabetes on these apps.

Objectives: The aim of this study is to perform a review of diabetes mobile apps to discover users’ sentiments and qualitatively examine the review comments to understand the perceptions of positive, neutral, and negative sentimental users of the apps.

Method: A total of 2678 user review comments obtained from the google play store were analysed from 47 diabetes mobile apps to understand user sentiments following clinical Self-management Indicators (SMIs) shown in previous research. Pearson correlation analysis was conducted to determine the association between the SMIs present in the apps’ and user review indicators such as rating score, user sentiment and the number of downloads. The users’ review comments were thematically screened using grounded theory to establish the themes to describe their perception of the apps.

Results: After evaluating SMIs such as weight tracking/BMI, sugar level monitoring, diet/Calories management, medication reminder, etc., 74.47% of the apps were found to have Sugar Level Monitoring(SLM) capabilities with 10.64% designed to track weight/BMI. There are 53.19% of the apps that can manage diet/calories and have data storage and security SMIs, however, less than 30% of them provide medication adherence, exercise management, doctor's appointment scheduling, and diabetes information repository. The number of the SMIs included in apps did not influence users’, but the value derived from the functionality of the apps.

Conclusions: Users are satisfied with the apps that are easy to use, setup, provide good analytics for blood sugar monitoring and have uncrowded graphical outputs and user interface. Proper data management and contemporary information about diabetes are among the identified challenges of the apps that were found to crash relentlessly on downloading, uploading, installing, and setup.

背景:了解糖尿病移动应用程序的功能是糖尿病自我管理的基础,因为许多糖尿病患者依赖这些应用程序。目的:本研究的目的是对糖尿病移动应用程序进行审查,以发现用户的情绪,并定性地检查审查评论,以了解应用程序的积极,中立和消极情感用户的看法。方法:分析47个糖尿病手机应用程序中从谷歌play store获取的2678条用户评论,了解用户按照前期研究的临床自我管理指标(clinical Self-management Indicators, SMIs)的感受。通过Pearson相关性分析来确定应用中存在的smi与用户评价指标(如评分、用户情绪和下载量)之间的关联。使用扎根理论对用户的评论进行主题筛选,以建立描述他们对应用程序的看法的主题。结果:通过对体重跟踪/BMI、糖水平监测、饮食/卡路里管理、用药提醒等SMIs进行评估,发现74.47%的app具有糖水平监测(SLM)功能,10.64%的app具有体重/BMI跟踪功能。有53.19%的应用程序可以管理饮食/卡路里,并具有数据存储和安全SMIs,然而,只有不到30%的应用程序提供药物依从性、运动管理、医生预约安排和糖尿病信息库。应用程序中包含的smi数量不会影响用户,但会影响应用程序功能产生的价值。结论:用户对应用程序的易用性、设置性、血糖监测分析能力强、图形输出和用户界面不拥挤等特点感到满意。适当的数据管理和有关糖尿病的最新信息是应用程序面临的挑战之一,这些应用程序在下载、上传、安装和设置时被发现会无情地崩溃。
{"title":"Text Mining and Grounded Theory for Appraising the Self-Management Indicators of Diabetes Mobile Apps","authors":"Chinedu I. Ossai ,&nbsp;Nilmini Wickramasinghe","doi":"10.1016/j.endmts.2021.100101","DOIUrl":"10.1016/j.endmts.2021.100101","url":null,"abstract":"<div><p><strong><em>Background:</em></strong> Understanding diabetes mobile apps functionality is fundamental to diabetes self-management because of the reliance of many patients with diabetes on these apps.</p><p><strong><em>Objectives:</em></strong> The aim of this study is to perform a review of diabetes mobile apps to discover users’ sentiments and qualitatively examine the review comments to understand the perceptions of positive, neutral, and negative sentimental users of the apps.</p><p><strong><em>Method</em></strong><em>:</em> A total of 2678 user review comments obtained from the google play store were analysed from 47 diabetes mobile apps to understand user sentiments following clinical Self-management Indicators (SMIs) shown in previous research. Pearson correlation analysis was conducted to determine the association between the SMIs present in the apps’ and user review indicators such as rating score, user sentiment and the number of downloads. The users’ review comments were thematically screened using grounded theory to establish the themes to describe their perception of the apps.</p><p><strong><em>Results:</em></strong> After evaluating SMIs such as weight tracking/BMI, sugar level monitoring, diet/Calories management, medication reminder, <em>etc.</em>, 74.47% of the apps were found to have Sugar Level Monitoring(SLM) capabilities with 10.64% designed to track weight/BMI. There are 53.19% of the apps that can manage diet/calories and have data storage and security SMIs, however, less than 30% of them provide medication adherence, exercise management, doctor's appointment scheduling, and diabetes information repository. The number of the SMIs included in apps did not influence users’, but the value derived from the functionality of the apps.</p><p><strong><em>Conclusions</em></strong><em>:</em> Users are satisfied with the apps that are easy to use, setup, provide good analytics for blood sugar monitoring and have uncrowded graphical outputs and user interface. Proper data management and contemporary information about diabetes are among the identified challenges of the apps that were found to crash relentlessly on downloading, uploading, installing, and setup.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"105770907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Nutritional supplementation of D-Ribose-L-Cysteine suppresses oxidative stress, spermatogenesis and steroidogenesis recovery in rats exposed to mercury chloride: histomorphometry and biochemical evidence 营养补充d -核糖- l -半胱氨酸可抑制氯化汞暴露大鼠的氧化应激、精子发生和类固醇生成恢复:组织形态学和生化证据
Q3 Medicine Pub Date : 2021-09-30 DOI: 10.1016/j.endmts.2021.100105
Sunday A. Adelakun , Babatunde Ogunlade , Obinna P. Fidelis , Adewale A. Ajao

Background

Mercury chloride (HgCl2) is known to cause reproductive dysfunction. The negative effects may be ameliorated with the use of certain antioxidants. Present study focused on impact of D-Ribose-L-Cysteine (DRLC) on mercury chloride-induced testicular toxicity in male rats.

Materials and methods

Forty-eight (48) adult male Sprague-Dawley rats weighing 150-200g randomized into six groups of eight (n=8) rats each. Group A treated with 1mg/Kg body weight (bwt) HgCl2; Group B received 30mg/Kg bwt of DRLC; Group C received 1mg/Kg bwt of HgCl2 and 30 mg/Kg bwt of DRLC; Group D received 1mg/Kg bwt of HgCl2 and 30mg/Kg bwt of Vit. C; Group E received 1mg/Kg bwt of HgCl2 and 30mg/Kg bwt of DRLC and 30 mg/Kg bwt of Vit. C; Group F served as control given normal saline orally for 8 weeks. Testicular histology, histomorphometry parameters, and other parameters such as sperm, luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (TT), reduced glutathione (GSH), glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD) and malondialdehyde (MDA) were investigated.

Results

Administration of HgCl2 disorganized seminiferous epithelium and widened the hypocellular interstitium; significantly decrease the sperm quality, TT, FSH, LH, CAT, GPx, GSH, SOD, and increases the MDA compared to control group. Co-administration of HgCl2, DRLC and Vit.C decrease the MDA and increase hormonal and antioxidant level; improved sperm quality and restored testicular histopathological alterations.

Conclusion

Intervening action of DRLC therefore, resulted in normal germinal cell layers, suppresses oxidative stress, spermatogenesis and steroidogenesis recovery in HgCl2 induced testicular toxicity.

众所周知,氯化汞(HgCl2)会导致生殖功能障碍。使用某些抗氧化剂可以减轻这种负面影响。本文主要研究了d -核糖- l -半胱氨酸(DRLC)对氯化汞致雄性大鼠睾丸毒性的影响。材料与方法48只体重150 ~ 200g的成年雄性Sprague-Dawley大鼠随机分为6组,每组8只,n=8。A组用1mg/Kg体重(bwt) HgCl2处理;B组给予30mg/Kg bwt的DRLC;C组给予1mg/Kg bwt的HgCl2和30mg /Kg bwt的DRLC;D组分别给予HgCl2 1mg/Kg bwt和Vit 30mg/Kg bwt。C;E组给予HgCl2 1mg/Kg bwt、DRLC 30mg/Kg bwt和Vit 30mg/Kg bwt。C;F组作为对照组,口服生理盐水8周。检测睾丸组织学、组织形态学参数及精子、促黄体生成素(LH)、促卵泡激素(FSH)、睾酮(TT)、还原型谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GPx)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、丙二醛(MDA)等指标。结果HgCl2使精原上皮组织紊乱,细胞间质增宽;与对照组相比,显著降低精子质量、TT、FSH、LH、CAT、GPx、GSH、SOD,增加MDA。同时给药HgCl2、DRLC和vitc可降低MDA,提高激素和抗氧化水平;改善精子质量,恢复睾丸组织病理学改变。结论DRLC的干预作用可使HgCl2致睾丸毒性小鼠的生殖细胞层数正常,抑制氧化应激、精子发生和甾体生成的恢复。
{"title":"Nutritional supplementation of D-Ribose-L-Cysteine suppresses oxidative stress, spermatogenesis and steroidogenesis recovery in rats exposed to mercury chloride: histomorphometry and biochemical evidence","authors":"Sunday A. Adelakun ,&nbsp;Babatunde Ogunlade ,&nbsp;Obinna P. Fidelis ,&nbsp;Adewale A. Ajao","doi":"10.1016/j.endmts.2021.100105","DOIUrl":"https://doi.org/10.1016/j.endmts.2021.100105","url":null,"abstract":"<div><h3>Background</h3><p>Mercury chloride (HgCl<sub>2</sub>) is known to cause reproductive dysfunction. The negative effects may be ameliorated with the use of certain antioxidants. Present study focused on impact of D-Ribose-L-Cysteine (DRLC) on mercury chloride-induced testicular toxicity in male rats.</p></div><div><h3>Materials and methods</h3><p>Forty-eight (48) adult male Sprague-Dawley rats weighing 150-200g randomized into six groups of eight (n=8) rats each. Group A treated with 1mg/Kg body weight (bwt) HgCl<sub>2</sub>; Group B received 30mg/Kg bwt of DRLC; Group C received 1mg/Kg bwt of HgCl<sub>2</sub> and 30 mg/Kg bwt of DRLC; Group D received 1mg/Kg bwt of HgCl<sub>2</sub> and 30mg/Kg bwt of Vit. C; Group E received 1mg/Kg bwt of HgCl<sub>2</sub> and 30mg/Kg bwt of DRLC and 30 mg/Kg bwt of Vit. C; Group F served as control given normal saline orally for 8 weeks. Testicular histology, histomorphometry parameters, and other parameters such as sperm, luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (TT), reduced glutathione (GSH), glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD) and malondialdehyde (MDA) were investigated.</p></div><div><h3>Results</h3><p>Administration of HgCl<sub>2</sub> disorganized seminiferous epithelium and widened the hypocellular interstitium; significantly decrease the sperm quality, TT, FSH, LH, CAT, GPx, GSH, SOD, and increases the MDA compared to control group. Co-administration of HgCl<sub>2</sub>, DRLC and Vit.C decrease the MDA and increase hormonal and antioxidant level; improved sperm quality and restored testicular histopathological alterations.</p></div><div><h3>Conclusion</h3><p>Intervening action of DRLC therefore, resulted in normal germinal cell layers, suppresses oxidative stress, spermatogenesis and steroidogenesis recovery in HgCl<sub>2</sub> induced testicular toxicity.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136899035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Endocrine and Metabolic Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1